The markets opened mixed with the Dow slipping 9 points to 13,232 while Nasdaq added 5 points to 3127 as home prices fell to their lowest level in ten years.
On the upside
ISTA Pharmaceuticals (Nasdaq: ISTA) received a patent for its PROLENSA once a day non steroidal anti-inflammatory product to treat ocular inflammation and pain after cataract surgery.
Shares of Arena Pharmaceuticals (Nasdaq: ARNA) continued rising after the European Medicines Agency accepted the biopharmaceutical's marketing application for the weight loss drug Lorcaserin.
On the downside
The Food and Drug Administration issued a complete response letter to MAP Pharmaceuticals (Nasdaq: MAPP) for its orally inhaled migraine treatment Levadex.
Total SA (NYSE: TOT) evacuated personnel from its Elgin, Franklin and West Franklin fields on Sunday due to a natural gas leak.
Apollo Group (Nasdaq: APOL) swung to a profit for the second quarter but the for profit educator warned of lower enrollment.
In the broad market, advancing issues barely edged out decliners by a slim margin on the NYSE while advancers were on par with decliners on Nasdaq. The Russell 2000 which tracks small cap stocks edged up a fraction to 846.